ARCHIVES

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

NCI Natural Product Drug Development To Get New Emphasis; Suggestions Of Critic Accepted

March 19, 1976

Levamisole/5-FU Could Save $226 Mil. If Fully Adopted, NCI Economist Says

April 20, 1990

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

Regulatory Agencies: FDA To Increase Fees For Mammography Facility Inspections

January 30, 1998

Ethics Commission To Continue Consideration Of Compensation For Injured Research Subjects

June 20, 1980

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013